Check out OMBP. Jason Napadano recently started coverage of them. His latest report states they are sitting on IP worth in the hundreds of millions and they have a current market cap of ~$10M.
Very unique business model in that several of the uses for AAT are already FDA approved (similar to NVIV's model).
Sentiment: Strong Buy
Just noticed our own Bob Langer is a director at ACTC, and holds almost 4 million shares. Interesting, but their message boards appear to be filled with children. What's this business about cleaning up the "business end"?
I like INO if their vaccine for HIV works, which strong phase 1 results indicate, then it could be huge. MNKD is also another one of my holdings. Even though they have a lot of debt their phase three results will be released in August which should add a nice uptrend to he current pps. Followed with an NDA form for the FDA and partnership. Al the CEO has already told his investors that if the FDA plays games he's going to China so in my opinion I see this going to approval. All else aside NVIV has crazy potential, if there technology can prove itself in upcoming human testing. I also like GALE for their breast cancer drug plus they have a pain drug for cancer that's already approved. The problem is, is that it has been getting beat down as of late. My thoughts to this is that the big investors want in and they are pushing it down to get the best price. Remember the stock market is like one big chess board, so choose your moves wisely, and always be five moves ahead.